Does LEPR Polymorphism Predict Variability in Weight Gain Induced by Mirtazapine in the Treatment of Late Life Depression?
Phase of Trial: Phase IV
Latest Information Update: 26 Apr 2016
At a glance
- Drugs Mirtazapine (Primary)
- Indications Major depressive disorder
- Focus Pharmacogenomic; Therapeutic Use
- 20 Apr 2016 Status changed from recruiting to completed.
- 18 Jul 2013 Planned end date changed from 1 Jun 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov.
- 01 Jun 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.